WITH LOW LIQUIDITY AND NO DIVIDEND ALLOCATIONRopharma shares are down 23% over the last two years
ANDREI IACOMI ( Translated by Cosmin Ghidoveanu)English Section / 11 decembrie 2019
• Marcel Murgoci, Estinvest: "Looking at it strictly from the point of view of the Price to Book Value indicator, we can say that the RPH stock is correctly valued"
The shares of Ropharma Brasov (RPH), the company operating the drug store chain of the same name, have followed a mostly downward trend over the last two years, with the price going down about 23%, between December 27, 2017 - December 6, 2019, way behind the BET Plus index, of which the stock is a part of, which rose almost 28%, over the same period.